CM 611 (Invokamet 150 mg / 1000 mg)
Generic Name: canagliflozin/metformin
Pill with imprint CM 611 is Purple, Capsule-shape and has been identified as Invokamet 150 mg / 1000 mg. It is supplied by Janssen Pharmaceuticals, Inc.
Invokamet is used in the treatment of cardiovascular risk reduction; diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Invokamet 150 mg / 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CM 611
Invokamet
- Generic Name
- canagliflozin/metformin
- Imprint
- CM 611
- Strength
- 150 mg / 1000 mg
- Color
- Purple
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 50458-0543
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
water,
polyethylene glycol 3350,
magnesium silicate,
titanium dioxide,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about Invokamet (canagliflozin / metformin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (2)
- Drug images
- Pricing & coupons
- En español
- Drug class: antidiabetic combinations
- FDA approval history
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.